流動負債 変化する 日付
AbbVie USD 43.1B 1.46B 2026-09
Alaunos Therapeutics USD 864K 269K 2026-06
Amgen USD 23.23B 2.27B 2026-09
Ardelyx USD 127.8M 4.42M 2026-09
Arrowhead Research USD 311.34M 27.99M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Biogen USD 3.9B 18.7M 2026-09
Corcept Therapeutics USD 177.68M 23.87M 2026-09
Curis USD 14.97M 898K 2026-03
Gilead Sciences USD 12B 982M 2026-09
J&J USD 55.46B 562M 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Novartis USD 32.52B 777M 2026-09
Novavax USD 329.84M 729K 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
TG Therapeutics USD 260.53M 7.97M 2026-09
Verastem USD 66.84M 5.42M 2026-03
Vertex Pharmaceuticals USD 5B 1.06B 2026-09